中文版     ENGLISH

泽尔瑞英.png

scan it,Follow us

News classification

Product

Contact

Hangzhou ZeErRui Chemical Co., Ltd

Add:No 317,Jingling Road,Guali Town,Xiaoshan District,Hangzhou,Zhejiang

Tel:+86-571-57153510

Mobile:+86-15267108660(Mrs. Pan)

Fax:+86-571-57153510

Zip Code:311241

E-mail:sales@zeerrui.com

Web:www.almarsal.com 


Eribulin Mesylate: Mechanism of Action of a Unique Microtubule-Targeting Agent

Your current position: Home >> News >> Industry news

Eribulin Mesylate: Mechanism of Action of a Unique Microtubule-Targeting Agent

Release date:2017-11-03 Author: Click:

Eribulin mesylate (eribulin), an analogue of the marine natural product halichondrin B, is a microtubule-depolymerizing drug that has utility in the treatment of patients with breast cancer. Clinical trial results have demonstrated that eribulin treatment provides a survival advantage to patients with metastatic or locally advanced breast cancer previously treated with an anthracycline and a taxane. Furthermore, a pooled analysis of two pivotal phase III trials has demonstrated that eribulin also improves overall survival in several patient subgroups, including in women with HER2-negative disease and triple-negative breast cancer. This review covers the preclinical research that led to the clinical testing and approval of eribulin, as well as subsequent research that was prompted by distinct and unexpected effects of eribulin in the clinic. Initial studies with halichondrin B demonstrated unique effects on tubulin binding that resulted in distinct microtubule-dependent events and antitumor actions. Consistent with the actions of the natural product, eribulin has potent microtubule-depolymerizing activities and properties that distinguish it from other microtubule-targeting agents. Here, we review new results that further differentiate the effects of eribulin from other agents on peripheral nerves, angiogenesis, vascular remodeling, and epithelial-to-mesenchymal transition. Together, these data highlight the distinct properties of eribulin and begin to delineate the mechanisms behind the increased survival benefit provided by eribulin for patients.

Related tags:?Eribulinmesylatesupplier

Last one:None
Next article:None

Recent browsing:

Related products:

Related news:

Service
share
Welcome to our message
Please enter the message content, we will contact you as soon as possible。
Full name
Full name
Telephone
Telephone
mailbox
mailbox
address
address
男人到天堂a在线百度,丁香五月天之婷婷开心,天天影院色香欲综合,日本三级在线线观看,无码自拍